TY - JOUR
KW - Adult
KW - buprenorphine
KW - Delayed-Action Preparations/therapeutic use
KW - Female
KW - Humans
KW - Male
KW - Naltrexone
KW - Narcotic Antagonists/therapeutic use
KW - Opioid-Related Disorders/drug therapy
KW - retention in care
KW - Retrospective Studies
KW - Extended-release
KW - opioid use disorder
KW - Opioids
KW - treatment retention
AU - M. D. Stein
AU - D. VanNoppen
AU - D. S. Herman
AU - B. J. Anderson
AU - M. Conti
AU - G. L. Bailey
A1 - 
AD - Boston University School of Public Health, Boston, MA 02118, United States of America; Behavioral Medicine and Addictions Research, Butler Hospital, Providence, RI 02906, United States of America. Electronic address: mdstein@bu.edu.; Behavioral Medicine and Addictions Research, Butler Hospital, Providence, RI 02906, United States of America.; Behavioral Medicine and Addictions Research, Butler Hospital, Providence, RI 02906, United States of America; Warren Alpert Medical School of Brown University, Providence, RI 02912, United States of America.; Behavioral Medicine and Addictions Research, Butler Hospital, Providence, RI 02906, United States of America.; Behavioral Medicine and Addictions Research, Butler Hospital, Providence, RI 02906, United States of America.; Warren Alpert Medical School of Brown University, Providence, RI 02912, United States of America; Stanley Street Treatment and Resources, Fall River, MA, 02720, United States of America.
BT - Journal of substance abuse treatment
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CY - United States
DO - 10.1016/j.jsat.2021.108661
JF - Journal of substance abuse treatment
LA - eng
M1 - Journal Article
PB - Elsevier Inc
PP - United States
PY - 2022
SN - 1873-6483; 0740-5472
SP - 108661
T1 - Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine
T2 - Journal of substance abuse treatment
TI - Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 34801283
U3 - 10.1016/j.jsat.2021.108661
VL - 136
VO - 1873-6483; 0740-5472
Y1 - 2022
Y2 - May
ER -